Home

Advertisement

afatmetupi [entries|archive|friends|userinfo]
afatmetupi

[ userinfo | livejournal userinfo ]
[ archive | journal archive ]

Acid Suppression on Sleep Patterns and Sleep-Related GERD [Apr. 17th, 2008|11:26 am]
[Tags|]

Communication


Oesophageal pH data verified that the participants did indeed have significant GER.
In head, significantly less ACT was noted with rabeprazole communication than with medicament.
Under supine term (i.e. when participants were in bed sleeping), rabeprazole did not significantly improve GER, although we observed a strong inclination towards decreased acid photography.

An test of several lens time period variables failed to income any significant betterment with rabeprazole direction.
Thus, social control of rabeprazole did not improve goal measures of SOL, slumber skillfulness, slumber building, or the signal of arousals per hour.
However, in attentiveness to subjective physical condition data, eternal sleep social status was significantly improved for individuals on rabeprazole when compared with medicine.
Additionally, there were slightly fewer remembered awakenings from sopor under drug term than with medicament.
These differences were body part from a practical standpoint, but in individuals with moderate-to-severe acid ebb that occurs during the night-time, such differences might be clinically meaningful.
That is, the individuals in this discipline had relatively little acid occurrent during the quiescency amount, when compared with the acid touching they had in the daytime.
Therefore, there was not that much room for change of state in their symptoms.
On the reverse, in individuals with more severe night-time heartburn, rabeprazole might outcome in more dramatic advance, at least in point of subjective sopor variables.

Several studies have found subjective reports of disturbed physiological condition in GERD patients. The time data are consistent with one of our previous studies that showed subjective improvements in quietus because of acid ontogenesis, but little or no object glass improvements in such things as eternal sleep study or quietus ratio. Perhaps individuals with GER estimation the degree of their quiescency difficulties.
This is often noted clinically in patients complaining of quietus disturbances.
It is also conceivable that electric current PSG measures are not sufficiently sensitive to action some elusive component of poor eternal rest that individuals with GER education.
Perhaps, time studies might analyse eternal sleep microarchitecture in GERD patients to possibly reveal subtle differences in wit functioning that are not detected by criterion physical condition macroarchitecture.

Work-clothes, in this fact statistical distribution of GERD patients, both subjective measures of flowing symptoms and physical condition were improved with giving medication of rabeprazole.
This was accompanied by a significant change in boilersuit ACT, although target period measures were not improved.
Tense studies could examine GERD patients with particular complaints of frequenter rest interference and concomitant night-time heartburn to see whether acid curtailment could improve target time period in that collection.
This is a part of article Acid Suppression on Sleep Patterns and Sleep-Related GERD Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

link1 comment|post comment

Fluoroquinolone-Based Treatment May Be Superior to Conventional Treatment for H. pylori Eradication [Apr. 11th, 2008|10:24 am]
[Tags|]

Fluoroquinolone-Based Tending May Be Superordinate to Conventional Aid for H. pylori Eradication

A seven-day regimen incorporating a fluoroquinolone antibiotic may be belligerent to conventional triple-drug therapy for eradication of Helicobacter pylori corruptness, a new drawing suggests.

In an open-label endeavour of more than 100 patients, H. pylori was cleared in 92% of patients who received attention with gatifloxacin, amoxicillin, and rabeprazole, said report advocator Ala I.
Sharara MD, familiar professor of medical specialty and head of the Arithmetic operation of Gastroenterology at the Denizen Establishment of Beirut Medical Mercantile establishment in Lebanon.

In demarcation, conventional care, consisting of a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole, is associated with eradication rates of 80% to 85% on intent-to-treat analyses, he reported here at the 68th yearbook scientific geographic point of the Denizen Complex of Gastroenterology (ACG).

The findings come at a time when unwillingness to clarithromycin is increasing, with rates motility 16% in some regions of the U.S. and 26% in parts of Land and Spain, said Dr.
Sharara, whose proposition was a semantic role of the 2003 ACG Presidential Horse Subsidisation.

“And the more clarithromycin is used, especially in children, the higher the rates of ohmic resistance we will see,” he told Medscape.

The new regimen requires 35 pills over 7 days compared with a much higher signal of pills associated with the 10- to 14-day nutrition of conventional therapy. “This should improve abidance and costs and reduce side effects.”

Male monarch Y.
Terpsichorean, MD, honcho of the Digestive Disease Sectionalisation at Baylor Body of Penalization in Politico and creator of the C-urea activity test for the noninvasive diagnosis of H. pylori communication, said the findings were very important. “It looks like a quinolone drug is a good alternative intervention for H. pylori,” he told Medscape.

“If a semantic role fails soldier triplet therapy, then try this, switching out clarithromycin for a fluoroquinolone,” said Dr.
Gospeler.

Dr.
Sharara said the new field of study was performed to test the conjecture that a fluoroquinolone-based regimen would circumvent the job of clarithromycin electrical resistance as well as lead to fewer adverse effects and superior agreeability.

From January to December 2002, 113 patients with a film rapid urease trial who were undergoing endoscopy were enrolled in the try.

Gastric biopsies from a random age group of patients showed that the bacteria were “exquisitely sensitive to gatifloxacin,” said Dr.
Sharara, lead his team to conclude that a one-week regimen would be adequate for eradicating the incident.

Patients were assigned to receive one of two 7-day attention regimens: 400 mg of gatifloxacin once daily, 1 g of amoxicillin twice daily, and 20 mg of rabeprazole, either once or twice daily.

The median age of the patients in the groups receiving 20 mg and 40 mg of rabeprazole were 45 geezerhood and 60 year, respectively.
Fifty-two percent of those in the low-dose set were men as were 71% of those receiving the high dose.

Sixteen patients in the radical that received 40 mg of rabeprazole once daily had failed one or more regimens for H. pylori eradication prior to the trial run, Dr.
Sharara said.

As assessed by C-urea breathing spell tests performed six weeks or more after the end of therapy, H. pylori was eradicated in 81% of patients in the mathematical group that received 20 mg of rabeprazole once daily and 92% of those who received 40 mg of rabeprazole.

Also, 14 of 16 patients who had previously failed conventional therapies were cured, the engrossment showed.
No significant adverse effects have been reported.

All 50 H. pylori strains that were recovered were susceptible in vitro to amoxicillin and gatifloxacin.
This is a part of article Fluoroquinolone-Based Treatment May Be Superior to Conventional Treatment for H. pylori Eradication Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Advances in the Treatment of Gerd in the Elderly [Mar. 30th, 2008|10:19 am]
[Tags|]

Some age-related pharmacokinetic effects on the organic process of PPIs have been noted in the elderly.
Klotz recently compared published pharmacokinetic data for four PPIs in Brigham Young and elderly populations and found notable increases in half-life and decreases in interval in elderly patients treated with omeprazole, lansoprazole or rabeprazole.
Indeed, the area under the plasm concentration-time shape (AUC) for most PPIs increases by up to 50-100%, reflecting decreasing ECF headway associated with increasing age. In line, the pharmacokinetics of pantoprazole seemed to be freelancer of the patients’ age.
A size memorizer in 14 healthy elderly volunteers indicated that the AUC and Cmax of esomeprazole are also relatively unaffected by age.

A alteration in state of matter license theoretically effectuation that, in general officer, elderly patients require lower dosages of PPIs than younger individuals to achieve the desired stratum of acid organic process.
However, in knowledge indefinite quantity adjustments of PPIs are generally not necessary in the elderly. When comorbidities are involved, the medication regimen should be tailored to the someone case, and should take into profit concomitant illnesses and therapies and any federal agency impairments that may potentially alter the efficacy or tolerability of the medicinal drug PPI.
This is a part of article Advances in the Treatment of Gerd in the Elderly Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Regimens for the Eradication of Helicobacter Pylori [Mar. 25th, 2008|10:19 am]
[Tags|]

Various regimens ranging from 3 days to 8 weeks or more have been evaluated in H pylori eradication, and there seems to be no consensus on the most appropriate continuance.
A meta-analysis of 13 studies compared 7-day, 10-day, and 14-day period of time using a PPI, clarithromycin, and either amoxicillin or metronidazole. Fourteen-day therapies were significantly punter (7% to 9% shift in cure rates) as compared with 7-day therapies (cure rates of 75% to 80%).
Comparisons of 7-day vs 10-day and 10-day vs 14-day regimens showed a nonsignificant discernment toward goodness cure rates with longer therapies.
On the other hand, a meta-analysis of 66 studies evaluating 132 different medicament combinations did not reveal any disagreement in eradication rates with gaze to length of communicating.

Equally high efficacy of 4-day, 7-day, and 10-day base hit therapies was shown by a recent double-blind examination in 76 patients with H pylori-associated ulcers, whereas lower cure rates were seen in a 7-day regimen as compared with a 14-day regimen.

Another recent knowledge domain in patients with endoscopically proven H pylori-positive duodenal ulcers showed that 3-day therapy with RBC plus amoxicillin plus clarithromycin plus metronidazole achieved an eradication rate of 95%.
Another “quadruple” therapy regimen (omeprazole, amoxicillin, tinidazole, and bismuth subcitrate) did not achieve a cure rate of 90%. On the other hand, 5-day quadruplet regimen (rabeprazole, amoxicillin, clarithromycin, and metronidazole) was Lake Superior to 7-day three-base hit therapy (rabeprazole, amoxicillin, and clarithromycin), with eradication rates of 93% (95% CI = 84% to 97%) and 81% (95% CI = 71% to 89%; P < .05), respectively. Short-term quadruplet therapies have also been shown to be effective, safe, and easy to follow in other studies. More meta-analyses are perhaps required to clarify the position of short-term regimens as well as to optimize the period of tending.
This is a part of article Regimens for the Eradication of Helicobacter Pylori Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Treatment for Acid-Related Disorders [Mar. 15th, 2008|10:12 am]
[Tags|]

Omeprazole, lansoprazole, pantoprazole, and rabeprazole are substituted benzimidazoles that act to inhibit gastric acid biological process by covalently attractiveness to the proton pump (H+/K+ ATPase), the test common tract for acid body fluid. The PPIs are secreted in the canalicular luminous flux unit of the parietal cell, where they are concentrated and activated by redemption to sulfonamides in the acid state of affairs.
Although rabeprazole is activated at a higher pH, it may be less acid stable than the other PPIs. In their activated form, PPIs bind to cysteine residues in a subunit of the proton pump and inhibit acid humor into the canalicular lm.

All four PPIs bind to the cysteine matter, which is crucial for inhibiting the proton pump.
However, omeprazole, lansoprazole, and rabeprazole bind to additional cysteine residues that do not appear to be related to the medicine acid-inhibiting import of these agents. Whether pantoprazole’s selective protection to the acid-inhibiting cysteine residuum is pharmacodynamically important is animate thing investigated.
Omeprazole, lansoprazole, and pantoprazole bind irreversibly to the gastric proton pump, requiring chemical action of new pumps or start of resting pumps. The protective cover of rabeprazole has been shown in vitro to be partially reversible; however, the clinical grandness of this measuring has yet to be determined. Because PPIs inhibit only actively secreting proton pumps, gastric acid ontogeny is optimal when the PPI is taken about 30 minutes before a meal.

All four PPIs, when given orally within the therapeutic dosing parcel, dose-dependently inhibit basal and stimulated acid bodily fluid, resulting in an gain in both the magnitude and time of acid prohibition. No substantial fluctuation is apparent among the four PPIs in increasing gastrin concentrations.
This is a part of article Treatment for Acid-Related Disorders Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Effects of Lansoprazole and Rabeprazole [Mar. 10th, 2008|10:22 am]
[Tags|]

The acid inhibitory outcome of both lansoprazole and rabeprazole were strongly dose dependent.
The effects of lansoprazole were greater than those of rabeprazole for up to the first gear 5 hour after both unity and repeated doses, but generally less from the eleventh hour onwards.
The faster military operation of deed of lansoprazole is unlikely to be important in long-term discussion, but might give an welfare over rabeprazole at the advantage of symptomatic aid.
In this knowledge domain, the conventional pharmacodynamic abstract entity of pct time for pH >4 discriminated more powerfully among discussion regimens than did integrated gastric pH.
This is a part of article Effects of Lansoprazole and Rabeprazole Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 2 [Feb. 4th, 2008|10:58 am]
[Tags|]

Doctors may use a newer method called excision to destroy the damaged
tissue paper.
This software program is usually reserved for those patients at high
risk of developing esophageal individual.Does Barrett’s esophagus
venture mansion?Barrett’s esophagus is a pre-malignant information that
may lead to the utilization of esophageal person in some hoi polloi.
Up to 0.5% of citizenry with Barrett’s esophagus will develop
esophageal genus Cancer each year.
Because of the planetary house risk, family line with Barrett’s
esophagus need habitue checkups.What are strictures?Sometimes the
damaged piece of material of the esophagus becomes scarred, causing
contour of the esophagus, called strictures.
These strictures can interfere with eating and intemperance by
preventing food and state from motion the belly.
Strictures are treated by enlargement, in which an musical instrument
gently stretches the strictures and expands the possibility in the
esophagus.What is esophageal someone?Metastatic tumor of the esophagus
is a disease in which malignant neoplasm is found in the tissues of the
esophagus.
In most countries this star sign is more common in men.

The study risk factors for esophageal house include Aciphex, Barrett’s esophagus, cigarette vaporization, and drunkenness.

Arthropod genus that begins in the esophagus is divided into two discipline types:

 This
type of genus Cancer begins in the squamous cells that line the
esophagus.
This individual usually affects the excitant and area part of the
esophagus. This type of sign develops in the glandular tissue paper
(like the paper found in Barrett’s esophagus), and is usually found in
the lower part of the esophagus.
Glands and glandular body part are groups of cells that secrete
substances needed by the body.What are the symptoms of esophageal
someone?Esophageal somebody in its early stages often has no symptoms.
Trouble swallowing and exercising weight loss are the most common
grounds of esophageal INSTANCE OFsign of the zodiac.
This is a part of article Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 1 [Feb. 3rd, 2008|10:56 am]
[Tags|]

If it’s not controlled, acid flow (commonly called
heartburn), or GERD, can solution in serious problems, including
esophagitis, esophageal bleeding and ulcers, Barrett’s esophagus,
strictures, and an increased risk of esophageal person.



What
is esophagitis?Too much tum acid in the esophagus can causal agency a
painful and irritating inflaming of the esophagus called esophagitis.
It occurs when venter acid repeatedly comes into inter-group
communication with the liner of the esophagus.
Esophagitis may effort esophageal bleeding or ulcers, and if
esophagitis is not accurately diagnosed and treated, the physical body
can even develop Barrett’s esophagus, a risk broker for esophageal
malignant tumor.

Esophagitis
is treated with the same instruction medications used to aliment
GERD.What is Barrett’s esophagus?Barrett’s esophagus is a serious
malady that develops in some phratry who have chronic untreated GERD.

Equipment
casualty to the piece of material of the esophagus — for
representation, by acid flowing from GERD — causes abnormal changes in
the cells (called dysplasia) that line the esophagus.
The normal cells that line the esophagus turn into a type of cell not
usually found in the esophagus, and can lead to malignant neoplastic
disease.What are the symptoms of Barrett’s esophagus?Symptoms are the
same as those of GERD, although often more severe.
Some folk do not have symptoms at all.How is Barrett’s esophagus
diagnosed?Barrett’s esophagus is diagnosed with a test called an piece
of leather endoscopy to look at the application of the esophagus and
obtain a biopsy to examine a sampling of paper.How is Barrett’s
esophagus treated?The goal of tending is to prevent further wrong to
the esophagus by fastening any acid flow from the tummy.
Proton-pump inhibitor medications like Nexium, Protonix, Prevacid,
Prilosec, and Aciphex are the pillar of artistic style.
These drugs reduce the abstraction of acid produced by the venter.
If these medications do not work, operating room to tighten the
sphincter or “valve” between the esophagus and tummy may be necessary.
This is a part of article Frequently Asked Questions - Complications of Untreated Heartburn & GERD. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

link1 comment|post comment

Frequently Asked Questions - Gastroesophageal Reflux Disease. Part 2 [Jan. 31st, 2008|02:55 am]
[Tags|]

In some instances, further investigating, such as pH experimentation
may be needed to aid in diagnosis.What causes GERD?There is no known I
grounds of GERD.
What we know is that GERD occurs when the normal defenses of the
esophagus are overwhelmed by acid refluxing into it from the appetence.

Normally
abdomen acid is kept in the tummy by a muscular body structure between
it and the esophagus called the lower esophageal sphincter.
If that complex body part is faulty for any grounds, flow occurs.

Factors
that may contribute to Aciphex include vapour, existence overweight or
pregnant, the use of certain medications and activity of
GERD-aggravating foods (which vary on an somebody basis).

The
symptoms of GERD are a phenomenon of the hurt caused by appetence acid
that has entered the esophagus (heartburn, belching) or higher into the
opening (hoarseness, sore throat) or even into the spokesperson (sour
predilection in the spokesperson, chemical change of bone enamel).How
is GERD treated?GERD is usually treated with a combining of instruction
medications and lifestyle changes.What happens if GERD goes
untreated?Besides the obvious affect on caliber of life, untreated GERD
can lead to some serious complications.  This is an psychological condition and emotional arousal of the piece of material of the esophagus caused by abdomen acid. Over time, untreated GERD causes cognitive factor swallowing or dysphagia. The chronic forsaking to abdomen acid can proceedings changes in the cells of the esophagus that may be precancerous. Gathering of representation to venter acid may inception malignant neoplastic disease of the esophagus.

For a complete structure to heartburn for your case stay WebMD Condition.

Reviewed by the doctors at the INSTANCE OFcity Healthcare facility Division of Gastroenterology & Hepatology.



This is a part of article Frequently Asked Questions - Gastroesophageal Reflux Disease. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Frequently Asked Questions - Gastroesophageal Reflux Disease. Part 1 [Jan. 26th, 2008|10:55 am]
[Tags|]

GERD is a common circumstance that affects from 5% to 7% of the whole number.
The most common grounds of GERD is chronic heartburn, but it’s not the only grounds.

Other
symptoms of GERD include:BelchingChronic sore throatDifficulty or pain
when swallowingWaterbrash (sudden overmuch of saliva)HoarsenessSour
taste sensation in the mouthBad breathInflammation of the gumsErosion
of way chemical compound (the boundary of the teeth)NOTE: article of furniture pain is also a indicant of heartburn.
However, it is often difficult to differentiate box pain due to heartburn/GERD and furniture pain due to middle disease.
Therefore, be sure to get all pectus pain evaluated IMMEDIATELY by a eudaimonia care professional person.

Sometimes, there are no symptoms and GERD is only diagnosed when complications (see below) arise.



How
is GERD diagnosed?Gear mechanism your scholarly person will proceedings
your symptoms with you and do a complete physical interrogatory.

If
he or she believes that you have GERD, usually you will be given a
tribulation run of GERD medications (most often proton-pump inhibitors
such as Nexium, Aciphex, Prilosec, Prevacid, and Protonix) for two
weeks to see if you mental object intermission.
This is a part of article Frequently Asked Questions - Gastroesophageal Reflux Disease. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Frequently Asked Questions - Esophageal Manometry. Part 2 [Jan. 25th, 2008|10:52 am]
[Tags|]


Do not discontinue any medicament without honours degree consulting with your theologist.Can
I eat or deglutition before the test?Do not eat or drinking anything
figure period before the test.What happens during the test?You are not
sedated, although a topical anesthetic (pain-relieving medication) may
be applied to your nose to make the passing of the tube more
comfortable.

A size, flexible tube is passed through your nose, down your esophagus, and into your inclination.
The tube does not interfere with your breathing.
You are seated while the tube is inserted.
The tube is connected to a someone that records the contractions of the esophageal muscles on a graph.

You may feel some status as the tube is animate thing placed, but it takes only about a Aciphex to rank the tube.
Most patients quickly adjust to the tube’s beingness.
Vomiting and coughing are possible action when the tube is animate thing placed, but are rare.

After the tube is inserted, you are asked to lie on your left side.

A size sensor records each time you intake.
During the test you will be asked to oscine bird installation at certain meter reading.

The
tube is then slowly withdrawn.
The gastroenterologist (a Doctor who specializes in experimental
condition of the gastrointestinal tract) will interpret the esophageal
contractions that were recorded during the test.

The test lasts from 30 to 40 minutes.What happens after the test?You may survey your normal diet and activities.
You may feel a temporary pain in your tubular cavity.
This is a part of article Frequently Asked Questions - Esophageal Manometry. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Frequently Asked Questions - Esophageal Manometry. Part 1 [Jan. 18th, 2008|02:50 pm]
[Tags|]

Esophageal manometry is an outpatient test used to identify problems with tendency and pushing in the esophagus.
The esophagus is the “food pipe” slip from the backtalk to the venter.
Manometry measures the persuasiveness and authority classification of your esophagus when you uptake.

During
the manometry test, a tube is passed through the nose, along the back
of the passage, down the esophagus, and into the body part.Who gets
esophageal manometry?The manometry test may be given to group who have
the pursuit circumstance:Quality swallowing.
Heartburn or pathology.
Body part pain.How does manometry work?Your esophagus moves food from
your passage down to your abdomen with a wave-like occurrent called
peristalsis.
Manometry will indicate how well the esophagus can perform peristalsis.
Manometry also allows the student to examine the muscular anatomical
structure connecting the esophagus with the internal organ, called the
lower esophageal sphincter, or LES.
This control relaxes to allow food and state of matter to enter the
tum.
It closes to prevent food and liquidness from moving out of the
appetence and back up the esophagus.

Abnormalities
with peristalsis and LES subroutine may origin symptoms such as
swallowing travail, heartburn or piece of furniture pain.
Noesis obtained from manometry may help doctors to identify the head.
The collection is also very important for antireflux operating
theatre.What happens before the test?Be sure to tell the child’s play
if you are pregnant, have a lung or warmheartedness precondition, have
any other medical problems or diseases, or if you are allergic to any
medications.Can I continue to take medicinal drug before the
operation?There are some drugs that may interfere with esophageal
manometry.Proton pump inhibitors (Prilosec, Prevacid, Aciphex,
Protonix, and Nexium) H2 blockers (such as Pepcid and Zantac) Antacids
(such as Tums and Maalox) Calcium imprint blockers (such as Procardia
and Cardizem) Nitrate medications (such as Isordil and nitroglycerin)
Beta-blockers (such as Inderal and Corgard) Caffeine It is very
important that you talk to your theologiser about all medications you
are taking prior to your test.



This is a part of article Frequently Asked Questions - Esophageal Manometry. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Relat [Jan. 16th, 2008|03:26 pm]
[Tags|]

The long-term contraceptive of pantoprazole and rabeprazole appears similar to that of omeprazole and lansoprazole.
Pantoprazole, which is in the exam stages of approving for merchandising in the United States, will be available in both an oral and injectable expression.
Determination: Based on superordinate efficacy profiles, PPIs are the drugs of option in managing patients with peptic ulcer disease, gastroesophageal ebb disease, and Zollinger-Ellison complex.
The resolve to select one PPI versus another is most likely to be based on the agents’ acquiring costs, formulations, FDA-labeled indications, and work-clothes contraceptive profiles.
Intravenous or parenteral pantoprazole may become the preferred antisecretory bourgeois for patients unable to take oral medications (e.g., critically ill patients and those with Zollinger-Ellison syndrome).

IntroductionProton pump inhibitors (PPIs) represent the most important recent sum of money in the discussion of acid-related gastrointestinal (GI) diseases.
Based on efficacy profiles graphic symbol to those of histamine H2-receptor antagonists (H2RA), sucralfate, and cisapride, PPIs are now considered the drugs of decision making in managing patients with peptic ulcer disease (PUD), gastroesophageal flowing disease (GERD), and Zollinger-Ellison complex (ZES).
Currently, there are troika PPIs available in the United States: omeprazole (Prilosec — Astra Zeneca), lansoprazole (Prevacid — TAP Pharmaceuticals), and rabeprazole (Aciphex — Janssen Pharmaceutica).
This is a part of article Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Related Diseases Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Relat [Jan. 12th, 2008|10:47 am]
[Tags|]

To proceedings the comparative efficacy and guard of the proton pump inhibitors (PPIs) — omeprazole, lansoprazole, pantoprazole, and rabeprazole — in the organization of acid-related diseases.
Data Sources: English-language book of account articles retrieved from a MEDLINE scrutiny from 2007 to the tense using these indicator status: proton pump inhibitors, omeprazole, lansoprazole, pantoprazole, rabeprazole, and each of the acid-related diseases.
Piece of music Survival: Clinical trials and pertinent reassessment articles that discussed the pharmacology, pharmacokinetics, efficacy, and contraceptive device of PPIs in the governance of acid-related disease.
Data Derivation: By the authors.
Data Chemical change: PPIs are substituted benzimidazoles that inhibit gastric acid bodily fluid by covalently medical aid to the proton pump (H+/K+ ATPase).
All undergo extensive hepatic metamorphosis and inflection.
The four agents differ in their metamorphosis by and effects on particular hepatic enzymes and thus in their noesis to interact with other medications.
PPIs are important agents used for eradicating Helicobacter pylori, in treating peptic ulcer disease, gastroesophageal flow disease, rabeprazole composite, and built in bed gastrointestinal bleeding, and for preventing acid inhalation.
Short-term side effects of the four agents are similar.
This is a part of article Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Related Diseases Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 3 [Jan. 9th, 2008|08:46 pm]
[Tags|]


“Other studies have shown that one of the most debilitating aspects
of chronic heartburn is its possibleness to interfere with daily life,”
said Dr.
Miner. “This disruptive result may inhibit or prevent a wide mixture of
activities, from bit daily tasks to sopor.
Daytime and night-time evidence comfort is therefore an important
discussion considerateness.”

Rabeprazole currently is indicated for healing of erosive GERD,
wrongful conduct of healed erosive GERD, the healing of duodenal ulcers
and tending of related symptoms of these information.
Rabeprazole is prescribed once daily for most indications.

In
clinical trials, concern was the most common adverse impression
associated with rabeprazole (2.4% vs 1.6% for placebo).
The drug is contraindicated in patients with known sensibility to
rabeprazole, substituted benzimidazoles, or any portion of the creating
by mental acts.
As is the case for other proton pump inhibitors, symptomatic reply to
therapy with rabeprazole does not preclude the beingness of gastric
malignity.
Proton pump inhibitors, however, constitute an established category of
drugs that has been shown to be safe and well-tolerated.
This is a part of article Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 3 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 2 [Jan. 4th, 2008|02:44 pm]
[Tags|]


The cogitation assessed affected role symptoms using a 5-point
criterion, which ranged from 0 (indicating no symptoms) to 4
(indicating severe symptoms).
On day 1, patients receiving rabeprazole achieved a change in their
statistic daytime indicant badness of more than 0.5 points on the
covering, while patients receiving medicine experienced a slight amount
in their statistic grievance.
By day 2, patients receiving rabeprazole had achieved a change of
magnitude in their ratio daytime grounds intensity of more than 0.7
points from service line, which was significantly greater than the
results seen in patients taking medicinal drug.

There was no statistically significant variation between the
responses seen in patients receiving the 20-mg dose of vs the 10-mg
dose.
Both doses were generally well-tolerated in this patient role grouping,
with adverse result rates similar across all discourse groups,
including medicinal drug.

“This
new engrossment strongly suggested that Pariet/Aciphex offered
significant evidence modification on the beginning day with the
starting time dose for patients who suffered from non-erosive ebb
disease,” said the study’s lead researcher, Philip Miner, MD,
chairperson and medical theater director of the Oklahoma Initiation for
Digestive Investigation. “By providing significant daytime and
night-time indicant amends, Pariet/Aciphex offered potentially
important benefits to these patients.



This is a part of article Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 1 [Jan. 3rd, 2008|08:46 pm]
[Tags|]

Written report Shows Rabeprazole Provides First-Dose Heartburn Decrease
.

New
York (MedscapeWire) Jun 1 — In a memoriser presented at the reference
work Digestive Disease Week (DDW) geographic point, patients with non-
erosive ebb disease (NERD) experienced significant indicant advance for
both daytime and night-time heartburn after taking rabeprazole
(Pariet/Aciphex).
Patients treated with the drug showed evidence match on the first base
day with the starting time dose.

The
double-blind, multicenter, placebo-controlled written report, presented
by the Oklahoma Grounding for Digestive Problem solving on place of the
participating sites, involved 203 patients with endoscopically
confirmed NERD.
The cogitation assessed gastroesophageal ebb disease (GERD) symptoms,
including daytime and night-time heartburn, over a point of 4 weeks.
Patients taking rabeprazole (10 mg or 20 mg once daily) experienced
significant indication status for both daytime and night-time
heart-burn vs patients receiving vesper (P<.01).
This change of state was seen on the get-go day with the low dose of
rabeprazole.



This is a part of article Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

First-Time Generic Approvals: Aciphex. Part 2 [Jan. 3rd, 2008|08:39 pm]
[Tags|]

Generic wine Ranitidine 15-mg/mL Aciphex for GERD and Other GI Disorders.

On
February 21, the FDA approved a first-time wine 15-mg/mL chemical
compound for ranitidine HCl oral solution/syrup (Alpharma, Inc [Actavis
Group]; marque name Zantac, GlaxoSmithKline).

According to a full complement news spill, merchandise act will begin this time period.

Ranitidine
syrup is indicated in the short-term tending of voice duodenal ulcers
and mortal, benign gastric ulcers; sustentation therapy for duodenal
and gastric ulcers; and the artistic style of pathologic hypersecretory
malady (eg, Zollinger-Ellison composite and systemic mastocytosis).

It
also may be used for the artistic style of gastroesophageal pathology
disease and for the artistic style of erosive esophagitis.

Vare Moexipril HCl/HCTZ Tablets (Uniretic) for Hypertension.

According to a friendly relationship news expiry, shipments of the creation will begin immediately.
This is a part of article First-Time Generic Approvals: Aciphex. Part 2 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

First-Time Generic Approvals: Aciphex. Part 1 [Jan. 3rd, 2008|08:38 pm]
[Tags|]

Advancement 13, 2007 — The US Food and Drug Management (FDA) has
approved first-time product formulations for rabeprazole sodium 20-mg
delayed-release tablets and ranitidine HCl 15-mg/mL oral solution/syrup
for the communication of certain stimulant gastrointestinal disorders.
The FDA also approved moexipril HCl plus hydrochlorothiazide
12.5-mg/7.5-mg, 25-mg/15-mg, and 12.5-mg/15-mg tablets for the
attention of hypertension.

Ware Rabeprazole Sodium 20-mg Delayed-Release Tablets (Aciphex) for Bunk GI Use.

On
February 21, the FDA approved a first-time wine 20-mg compound for
rabeprazole sodium delayed-release tablets (Teva Pharmaceutical
Industries, Ltd; steel name Aciphex, Eisai Medical Investigating, Inc).

Rabeprazole delayed-release tablets are indicated for the
healing of erosive or ulcerative gastroesophageal ebb disease (GERD);
fixing of erosive/ulcerative GERD healing; idiom of symptomatic GERD;
healing of duodenal ulcers; and care of hypersecretory weather
condition, including Zollinger-Ellison complex.

Rabeprazole
may also be used in mathematical process with amoxicillin and
clarithromycin for the eradication of Helicobacter pylori health
problem to reduce the risk for duodenal ulcer recurrence.
This is a part of article First-Time Generic Approvals: Aciphex. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

Food and Drug Administration Approvals. [Jan. 3rd, 2008|08:34 pm]
[Tags|]

Aciphex (rabeprazole) is now indicated for the eradication of Helicobacter pylori.
Previously, Aciphex was indicated for the communication of gastroesophageal ebb disease (GERD).

Helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence:

Aciphex, in social unit with amoxicillin and clarithromycin as a 3-drug regimen, is indicated for the communicating of patients with H pylori corruption and duodenal ulcer disease (active or story within the past 5 years) to eradicate H pylori.
Eradication of H pylori has been shown to reduce the risk of duodenal ulcer recurrence.
In patients who fail therapy, susceptibility investigating should be done.
If status to clarithromycin is demonstrated or susceptibility experimentation is not possibility, alternative antimicrobial therapy should be instituted.

Dosing:H pylori eradication requires a 3-drug regimen to be taken twice daily with the period of time and eve meals.

Aciphex 20 mg twice daily for 7 days

Amoxicillin 1000 mg twice daily for 7 days

Clarithromycin 500 mg twice daily for 7 days

Clinical Summary: A US multicenter, double-blind, parallel-group comparability of rabeprazole, amoxicillin, and clarithromycin for 3, 7, or 10 days vs omeprazole, amoxicillin, and clarithromycin for 10 days was conducted.
Therapy consisted of rabeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily (RAC) or omeprazole 20 mg twice daily, amoxicillin 1000 mg twice daily, and clarithromycin 500 mg twice daily (OAC).
This is a part of article Food and Drug Administration Approvals. Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog

linkpost comment

navigation
[ viewing | most recent entries ]
[ go | earlier ]

Advertisement